Introduction
Breast milk is considered a complete food for the newborn and breast feeding is known to provide a wide range of health benefits to both mother and the baby. The World Health Organization (WHO) recommends exclusive breastfeeding for the first six months of an infant's life, and continued breastfeeding with complementary foods for up to two years of age (1) . However, when a mother's milk is not available, infant milk formula is considered as an effective alternative. Cow milk-based infant formulas are widely used, but goat milk-based products are becoming increasingly popular as goat's milk is considered to be more similar to human milk compared with cow's milk.
This includes higher levels of oligosaccharides in goat's milk relative to milk of other mammalian species (2) and lower levels of α-S1 casein (3) . Goat's milk is also reported to exhibit significant homology in lactoferrin N-glycans with human milk" (4) .
Human milk is known to contain high concentrations (5-20g/L in mature milk) and diversity of oligosaccharides (5, 6) . Several studies have shown that oligosaccharides, particularly HMOs, are effective in selectively promoting t he growth of bifidobacteria and shaping the composition of intestinal microbiota, preventing adhesion of pathogens to intestinal mucosa and reducing the risk of bacterial, viral and parasitic infections, modulating immune and intestinal immune cell funct ion, lowering the risk of necrotizing enterocolitis and providing nutrients (sialic acid) for brain development and cognition (7 -12) . Especially, 2'-fucosylactose (2'-FL) has been reported to be important in protecting infants against gut infections (13, 14) . This has stimulated efforts by infant formula manufacturers to produce infant formulas that closely resemble human milk in composition and performance (15) . However, this process is challenging given that oligosaccharides in goat's or cow's milk exhibit limited diversity and are present at significantly lower concentrations compared with those in human milk (16 -20) . Importantly, the complexity of HMOs makes it almost impossible for these to be duplicated in infant formulas (2 1 ) . To overcome this challenge, modern infant formulas are commonly fortified with fructooligosaccharides (FOS) and galactooligosaccharides (GOS) (22) .
However, their effectiveness in conferring health benefits similar to those of breast milk remains to be proven (23; 24) . It has previously been shown that high heat treatment could cause degradation or change to the structure of some oligosaccharides (25, 26) . How the heat treatments applied during manufacture of infant formula (milk pasteurization and exposure to temperatures of 180-220°C during spray drying (27) ) affect the presence and functionality of naturally present or added oligosaccharides in infant formula remains unknown. Only a handful of studies to date have attempted to quantify the amount and types of milk oligosaccharides present in infant formula products. The primary objective of this study was to investigate the diversity and concentration of oligosaccharides present in goat's milk and goat milkbased infant formula and their prebiotic and anti-pathogen adhesion properties.
Materials and Methods

Oligosaccharide Standards
Oligosaccharide standards were purchased from Dextra Laboratories, Reading, UK. These
Lacto-N-hexaose (LNH), 3'-Galactosyllactose (3'-GSL), 4'-Galactosyllactose (4'-GSL), 6'-Galactosyllactose (6'-GSL), and Disialyllactose (DSL). Oligosaccharide standards which were received in powder form were reconstituted with Milli-Q water (22±2°C) to make a stock solution at a concentration of 1 g/L. Stock solutions were further diluted with Milli-Q water to give a final concentration range of 0.1 g/L to 0.001 g/L.
Preparation of oligosaccharides
Oli6 Stage 1 (S1-GIF) and Stage 2 goat's milk infant formulas (S2-GIF) and raw goat milk (pooled milk from a group of ten Saanen goats) were obtained from Nuchev Pty Ltd, Melbourne, Australia.
Galactooligosacchar ide mixt ure (GOS) was purchased from New Francisco (Yunfu Cit y).
Biotechnology Corporation Ltd, China (King-Prebiotics® GOS-700-P, Batch number 17003). Goat's milk infant formula was reconstituted according to manufacturer's instructions. GOS was reconstituted to 20g/L, whilst concentrations of milk oligosaccharides extracted from infant formula were adjusted to match typical levels in reconstituted goat's milk infant formula. Milk samples were centrifuged at 4000 ×g for 30 min at 4ºC to remove remaining milk lipids. Equal volumes of MilliQ water were added to defatted milk and subsequently filtered through a 10kDa molecular weight cut -off filter (Amicon® Centrifugal Filters, Merck, Australia) in a centrifuge (4000 ×g for 30 min). The clear filtrate was assumed to contain all oligosaccharides. Extracts were filtered with Millipore 0.45µm syringe filter.
Oligosaccharide Quantification by LC-MS
Analysis of oligosaccharides was performed based on the protocols of Liu et. al. (28) ; this method was found to be highly accurate and sensitive in detecting oligosaccharides (limit of detection of <0.1 ng and accuracy of 95 to 105% for a variety of spiked oligosaccharides).
Chromatographic separation of milk oligosaccharides was achieved via a Kinetex hydrophilic and processed using the Xcalibur software package (Thermo Scientific).
Evaluation of Prebiotic Properties
Two For growth experiments, modified MRS (mMRS) was used in which glucose was omitted unless performed and the cells re-cultured in a sterile flask pre-filled with fresh media (density of 10 5 cells/mL). For anti-adhesion studies, 24-well plates were seeded with 5 x 10 5 cells per well and incubated as before to obtain confluent monolayers. One day prior to experimentation, the media w a s r e p l a c e d w i t h f r e s h m e d i a w i t h o u t a n y a n t i b i o t i c -a n t i m y c o t i c .
Anti-adhesion study with Caco-2 cell monolayer
The protocol used was based on those of earlier studies with slight modifications ( 3 3 , 3 4 ) .
Escherichia coli NCTC 10418 and Salmonella typhimurium were from RMIT University's culture anti adhesion bacteria count control sample bacteria count sample bacteria count control 100 Results for LC/MS analyses, and growth and adhesion assays are expressed as mean ± standard error.
For experiments involving bacterial cultures, the difference between each treatment group was tested using one-way ANOVA and Tukey's multiple comparison tests. Statistical significance was defined as a p value of <0.05. All statistical analyses were performed using GraphPad Prism (GraphPad Prism version 8 for Windows, GraphPad Software).
Results
LC-MS Quantification of Milk Oligosaccharides
The high throughput analytical method used in this study was effective in identifying oligosaccharides pr esent in s ignificant quant it ies wit hout r equir ing sa mp le co ncent r at io n . A t ot al o f 14
oligosaccharides were found to be present in S1-GIF and S2-GIF. This included seven major (predominant) and seven minor (present in small amounts) oligosaccharides (Table 1 ; Figures 1-3 ).
3'-GSL and 6'-GSL were grouped together as triose sugars due to their complex chromatograph profiles (Figure 4 ). Of the 14 oligosaccharides, five (2'-FL, 3'-SL, 6'-SL, LNT and LNH) were structurally similar to those found in human breast milk (Table 1 ). There was no d i f fer e nc e in t he c hr o mat o gr ap h ic p r o fi le s o f S 1 -GI F a nd S 2 -GI F ( d at a no t sho w n) .
The oligosaccharide profile of goat's milk was similar in diversity to that of S1-GIF and S2-GIF with a few minor differences. One of the minor milk oligosaccharides, N-acetyl-glucosaminyllactose (NAL, m/z 544.18) was found to be absent in raw goat's milk (Table 1 , Figure 3) , and S2-GIF had slightly higher abundance of 6'-glycolyl-neuraminyl-lactose (NGL, m/z 648.19). Furthermore, the chromatographic profile of GOS was dominated by 3'-GSL and 6'-GSL that were also detected in goat's milk (Figure 4 ). It also implies that the total concentration of triose sugars identified in this study included GOS. For both GIFs prepared according to the manufacturer's instructions, oligosaccharide concentrations were similar to those found in normal unpasteurized goat's milk (Table 1) . 
Goat Milk Oligosaccharides Promote Bifidobacterium and Lactobacillus Growth
As shown in Figure 5 , the growth rate of B. animalis BB12 and B. longum BB536 was (currently being planned) to confirm these benefits in human subjects.
Goat Milk Oligosaccharides Prevent E. coli and S. typhimurium Adhesion to Caco-2 monolayer
Adhesion of E. coli NCTC 10418 and S. typhimurium were found to be inhibited by oligosaccharides present in S1-GIF and S2-GIF ( Figure 6 ) and no statist ically significant differences were observed between S1 and S2 formulas. Purified GOS was also effective at preventing adhesion of pathogens to Caco-2 cells, to at least the same degree. Interestingly, oligosaccharides purified from S1-GIF, S2-GIF and GOS appeared to be slightly more efficient at inhibiting E. coli NCTC 10418 adhesion to Caco-2 cells compared with S. typhimurium, at least for the isolates we examined here. In our study, lactose had no significant protective effect.
Discussion
The diverse array of highly complex oligosaccharides present in human breast milk (HMOs) is considered to be of vital importance in promoting the growth of beneficial bacteria in the infant gut, conferring protection against intestinal infections and promoting the development and maturation of the immune system (9; 14) . Compared to this, oligosaccharides found in bovine and caprine milk exhibit lesser diversity and complexity, and are found in relatively smaller amounts. As a result, the amount and nature of natural milk oligosaccharides present in either caprine or bovine milk-based infant formulas, and their effectiveness in conferring gut and immune health benefits on the infant, similar to those of breast milk, remains to be determined and is of significant research interest.
The results of the present study show that goat's milk-based infant formula contains significant amounts and a diverse array of oligosaccharides, many of which are structurally similar to HMOs. To our knowledge, this is the first such report showing such richness of oligosaccharides in goat's milk-based infant formula and their similarity to HMOs. Fourteen oligosaccharides, including seven major oligosaccharides were det ected in goat 's milk-based infant formula. Of t hese, five oligosaccharides are also found in human breast milk (Table 1 ). Goat's milk was also found to contain a similar number of oligosaccharides. Notably, the number of oligosaccharides detected in this study is significantly lower than that reported previously in goat's milk ( 2 0 ; 3 5 -41) . This is probably due to major differences in the methods used in these studies. The present study used a high throughput method that was aimed at detecting only quantifiable oligosaccharides; the samples used in this study involved the reconstitution of powders according to manufacturer's instructions for infant use and involved no sample concentration steps. In contrast, all earlier studies have employed methods involving significant enrichment of oligosaccharides with the aim to detect all oligosaccharides, including those present in trace amounts. Using a similar method, we detected 37 oligosaccharides in goat's milk in earlier studies (Leong et. al., unpublished) . Similar profile and diversity of oligosaccharides detected in raw goat's milk and goat's milk-based infant formula suggests that oligosaccharides are not affected by heat treatment used during manufacture of infant formula.
As in human breast milk, fucosylated and sialylated oligosaccharides were found to be the dominant oligosaccharides present in goat's milk-based infant formula. 2'-FL is the most abundant oligosaccharide in human milk (35, 42) and is the focus of significant commercial and regulatory interest. It has been shown to play a significant role in anti-infection properties of breastmilk; for example, infants with high levels of 2'FL have been shown to e hibit greater resistance to ST-E coli and Campylobacter-associated diarrhoea (43) . Oligosaccharides resist digestion in the small i n t e s t i n e a n d r e a c h t h e c o l o n i n t a c t w h e r e they are known to influence the structure and function of gut microbiota. For example, several studies have shown that HMOs are effective in selectively promoting the growth of beneficial bacteria, such as Bifidobacterium bifidum that dominate the gut microflora of breast fed infants (44 -47) .
The ability of HMOs and a mixture of FOS/GOS to promote the growth of bifidobacteria and lactobacilli in-vitro also has been demonstrated (48) . In the present study, goat milk oligosaccharides were found to exhibit similar prebiotic properties. They were found to be effective in promoting the growth of both Bifidobacterium and Lactobacillus species. Furthermore, oligosaccharides derived from both stage 1 and stage 2 goat's milk-based infant formula appeared to be more efficient at promoting the growth of B. longum BB536 and L casei 2607 than GOS. Whether this suggests a stronger prebiotic activity of goat milk oligosaccharides compared with GOS generally or is simply a reflection of bacterial species and/or strain-selectivit y in substrate utilisation is not clear (49) .
Differences in the ability of bifidobacteria and lactobacilli in their ability to utilize carbohydrates such as lactose GOS and lactulose has also been previously reported (50) . Lactose is highly likely to be present in the goat's milk infant formula oligosaccharide fractions, however the relatively insignificant growth-promoting effect of lactose, especially for bifidobacteria, compared with that for S1 and S2
fractions, suggests that the growth enhancement observed with S1 and S2 was largely due to oligosacchar ides. Furt her more, t he goat 's milk infant formula was found in our st udy to be r ich in 3'-SL, 6'-SL and 2'-FL, and the ability of B. longum and B. infantis to selectively ferment t he se o ligo sac c har ide s t o get her w it h s i m i la r it ie s in t he gut mic r o bio t a co mp o s it io n of infant s fed goat 's milk-based infant formula compared wit h breast-fed babies, has also been recently reported (51) .
The results of our study further showed that oligosaccharide enriched fractions prepared from both stage 1 and stage 2 goat's milk-based infant formula were effective in reducing the adherence of E coli and S. typhimurium to Caco-2 cells, as similarly reported for HMOs (41, 46) . Lower incidence of gastrointestinal infections in breast-fed infants compared with formula-fed infants (52) and a role for HMOs in this protection has been reported (53) . We found differences in the anti-adhesion efficacy against two different enteric pathogens to Caco-2 cells when pre-incubated and co-cultured with the same GIF oligosaccharide fractions, although further strains or isolates of these pathogens need to be tested before making a definitive conclusion. However, it is significant in this regard that Coppa et.al. (34) found species differences between Escherichia coli, Vibrio cholerae, and Salmonella fyris, in experiments using HMOs and (like us) Caco-2 cells. Whilst some recent studies have reported that oligosaccharides from human, cow and goat's milk (54, 55) are effective in inhibiting the adhesion of E.
coli to gut cells, t hese experiment s were conducted using much higher concentrations of oligosaccharides than we used in our study, suggesting the possibility of a dose-dependent effect. In our study GOS was at least equally as effective as goat milk oligosaccharides in preventing the adhesion of E. coli and S. typhimurium (by 52.4% and 35% respectively compared with the negative control; see Figure 6 ).
Attachment of pathogens to specific receptors on the gut epithelial cells is a critical step in host colonisat ion and infect ion. Carbohydrate chains form a major component of cell surface membrane, and lactose being a core saccharide of glycolipids represents a major binding site for bacteria (56, 57) . Some pathogens also bind to lectins in attempt to colonize gut epithelial surfaces and the lectin binding requires either sialyl or fucose groups to be present on the cognate glycan binding partners (14) . The resemblance of certain GOS to saccharide-containing glycoproteins used by many pathogens to attach to intestinal cells has also been reported (58) . Due to structural similarities between goat milk oligosaccharides and gut cell surface carbohydrate groups, these compounds, especially sialylated and fucosylated oligosaccharides, may reduce pathogen adhesion to gut epithelial cells by acting as soluble analogues of host cell receptors and/or changing the expression of such structures (59 -61) . In addition, oligosaccharides have also been shown to mediate protection against intestinal pathogens by enhancing immune function (11) .
T o g e t h e r , t h e s e r e s u l t s c o m b i n e d wit h the results of our study show that oligosaccharides present in goat milk-based infant formula have strong prebiotic and anti-infection properties, and may confer protection against gastrointestinal infect ions to the infant. Further studies are required to confirm if this is so. 
